{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:16:14Z","timestamp":1783343774602,"version":"3.54.6"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s42770-023-01239-0","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T05:34:54Z","timestamp":1705988094000},"page":"391-402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Current global status of Candida auris an emerging multidrug-resistant fungal pathogen: bibliometric analysis and network visualization"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0951-0886","authenticated-orcid":false,"given":"Hamza","family":"Ettadili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1400-6377","authenticated-orcid":false,"given":"Caner","family":"Vural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"1239_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12281-012-0094-x","volume":"6","author":"ME Brandt","year":"2012","unstructured":"Brandt ME, Lockhart SR (2012) Recent taxonomic developments with candida and other opportunistic yeasts. Curr Fungal Infect Rep 6:170\u2013177. https:\/\/doi.org\/10.1007\/s12281-012-0094-x","journal-title":"Curr Fungal Infect Rep"},{"key":"1239_CR2","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1128\/jcm.29.8.1702-1710.1991","volume":"29","author":"D Soll","year":"1991","unstructured":"Soll D, Rudolph G, Jan S et al (1991) Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J Clin Microbiol 29:1702\u20131710. https:\/\/doi.org\/10.1128\/jcm.29.8.1702-1710.1991","journal-title":"J Clin Microbiol"},{"key":"1239_CR3","doi-asserted-by":"publisher","unstructured":"Uthayakumar D, Sharma J, Wensing L, Shapiro RS (2020) CRISPR-based genetic manipulation of Candida species: historical perspectives and current approaches. Front Genome Ed 2. https:\/\/doi.org\/10.3389\/fgeed.2020.606281","DOI":"10.3389\/fgeed.2020.606281"},{"key":"1239_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2147\/IDR.S197531","volume":"12","author":"MJ Navarro-Arias","year":"2019","unstructured":"Navarro-Arias MJ, Hern\u00e1ndez-Ch\u00e1vez MJ, Garc\u00eda-Carnero LC et al (2019) Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells. Infect Drug Resist 12:783\u2013794. https:\/\/doi.org\/10.2147\/IDR.S197531","journal-title":"Infect Drug Resist"},{"key":"1239_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mbo3.578","volume":"7","author":"J Osei Sekyere","year":"2018","unstructured":"Osei Sekyere J (2018) Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen 7:1\u201329. https:\/\/doi.org\/10.1002\/mbo3.578","journal-title":"Microbiologyopen"},{"key":"1239_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofac559","volume":"10","author":"SE Kidd","year":"2023","unstructured":"Kidd SE, Abdolrasouli A, Hagen F (2023) Fungal nomenclature: managing change is the name of the game. Open Forum Infect Dis 10:1\u201315. https:\/\/doi.org\/10.1093\/ofid\/ofac559","journal-title":"Open Forum Infect Dis"},{"key":"1239_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-022-01052-8","volume":"11","author":"R Thoma","year":"2022","unstructured":"Thoma R, Seneghini M, Seiffert SN et al (2022) The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literatu. Antimicrob Resist Infect Control 11:1\u201311. https:\/\/doi.org\/10.1186\/s13756-022-01052-8","journal-title":"Antimicrob Resist Infect Control"},{"key":"1239_CR8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/jac\/dkx480","volume":"73","author":"A Chowdhary","year":"2018","unstructured":"Chowdhary A, Prakash A, Sharma C et al (2018) A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother 73:891\u2013899. https:\/\/doi.org\/10.1093\/jac\/dkx480","journal-title":"J Antimicrob Chemother"},{"key":"1239_CR9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/myc.13477","volume":"65","author":"A Izadi","year":"2022","unstructured":"Izadi A, Aghaei Gharehbolagh S, Sadeghi F et al (2022) Drug repurposing against Candida auris: a systematic review. Mycoses 65:784\u2013793. https:\/\/doi.org\/10.1111\/myc.13477","journal-title":"Mycoses"},{"key":"1239_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","volume":"53","author":"K Satoh","year":"2009","unstructured":"Satoh K, Makimura K, Hasumi Y et al (2009) Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53:41\u201344. https:\/\/doi.org\/10.1111\/j.1348-0421.2008.00083.x","journal-title":"Microbiol Immunol"},{"key":"1239_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1101\/2020.01.06.896548.87","volume":"18","author":"A Chakrabarti","year":"2020","unstructured":"Chakrabarti A, Singh S (2020) Multidrug-resistant Candida auris: an epidemiological review. Expert Rev Anti-Infect Ther 18:551\u2013562. https:\/\/doi.org\/10.1101\/2020.01.06.896548.87","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"1239_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.mycmed.2019.04.004","volume":"29","author":"S Mahmoudi","year":"2019","unstructured":"Mahmoudi S, Agha Kuchak Afshari S, Aghaei Gharehbolagh S et al (2019) Methods for identification of Candida auris, the yeast of global public health concern: a review. J Mycol Med 29:174\u2013179. https:\/\/doi.org\/10.1016\/j.mycmed.2019.04.004","journal-title":"J Mycol Med"},{"key":"1239_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3201\/eid2302.161320","volume":"23","author":"L Sherry","year":"2017","unstructured":"Sherry L, Ramage G, Kean R et al (2017) Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis 23:328\u2013331. https:\/\/doi.org\/10.3201\/eid2302.161320","journal-title":"Emerg Infect Dis"},{"key":"1239_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11046-022-00669-y","volume":"187","author":"L Rossato","year":"2022","unstructured":"Rossato L, Simionatto S, Serafini MR, Alves IA (2022) New technologies to diagnose and treat a multidrug-resistant Candida auris: a patent review. Mycopathologia 187:535\u2013546. https:\/\/doi.org\/10.1007\/s11046-022-00669-y","journal-title":"Mycopathologia"},{"key":"1239_CR15","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1080\/22221751.2022.2125349","volume":"11","author":"B Spruijtenburg","year":"2022","unstructured":"Spruijtenburg B, Badali H, Abastabar M et al (2022) Confirmation of fifth Candida auris clade by whole genome sequencing. Emerg Microbes Infect 11:2405\u20132411. https:\/\/doi.org\/10.1080\/22221751.2022.2125349","journal-title":"Emerg Microbes Infect"},{"key":"1239_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/mgen.0.000979","volume":"9","author":"X Li","year":"2023","unstructured":"Li X, Mu\u00f1oz JF, Gade L et al (2023) Comparing genomic variant identification protocols for Candida auris. Microb Genom 9:1\u201319. https:\/\/doi.org\/10.1099\/mgen.0.000979","journal-title":"Microb Genom"},{"key":"1239_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/myc.13470","volume":"65","author":"H Zerrouki","year":"2022","unstructured":"Zerrouki H, Ibrahim A, Rebiahi SA et al (2022) Emergence of Candida auris in intensive care units in Algeria. Mycoses 65:753\u2013759. https:\/\/doi.org\/10.1111\/myc.13470","journal-title":"Mycoses"},{"key":"1239_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JCM.00007-19","volume":"57","author":"RM Welsh","year":"2018","unstructured":"Welsh RM, Sexton DJ, Forsberg K et al (2018) Insights into the unique nature of the east asian clade of the emerging pathogenic yeast candida auris. J Clin Microbiol 57:1\u20135. https:\/\/doi.org\/10.1128\/JCM.00007-19","journal-title":"J Clin Microbiol"},{"key":"1239_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.mycmed.2018.06.007","volume":"28","author":"AL Bidaud","year":"2018","unstructured":"Bidaud AL, Chowdhary A, Dannaoui E (2018) Candida auris: an emerging drug resistant yeast \u2013 a mini-review. J Mycol Med 28:568\u2013573. https:\/\/doi.org\/10.1016\/j.mycmed.2018.06.007","journal-title":"J Mycol Med"},{"key":"1239_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/myc.13471","volume":"65","author":"N Vaseghi","year":"2022","unstructured":"Vaseghi N, Sharifisooraki J, Khodadadi H et al (2022) Global prevalence and subgroup analyses of coronavirus disease (COVID-19) associated Candida auris infections (CACa): A systematic review and meta-analysis. Mycoses 65:683\u2013703. https:\/\/doi.org\/10.1111\/myc.13471","journal-title":"Mycoses"},{"key":"1239_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jbusres.2021.04.070","volume":"133","author":"N Donthu","year":"2021","unstructured":"Donthu N, Kumar S, Mukherjee D et al (2021) How to conduct a bibliometric analysis: an overview and guidelines. J Bus Res 133:285\u2013296. https:\/\/doi.org\/10.1016\/j.jbusres.2021.04.070","journal-title":"J Bus Res"},{"key":"1239_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/feduc.2021.666087","volume":"6","author":"SKM Brika","year":"2021","unstructured":"Brika SKM, Algamdi A, Chergui K et al (2021) Quality of higher education: a bibliometric review study. Front Educ 6:1\u201315. https:\/\/doi.org\/10.3389\/feduc.2021.666087","journal-title":"Front Educ"},{"key":"1239_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/10447318.2020.1860516","volume":"37","author":"H Tan","year":"2021","unstructured":"Tan H, Sun J, Wenjia W, Zhu C (2021) User experience & usability of driving: a bibliometric analysis of 2000-2019. Int J Hum Comput Interact 37:297\u2013307. https:\/\/doi.org\/10.1080\/10447318.2020.1860516","journal-title":"Int J Hum Comput Interact"},{"key":"1239_CR24","doi-asserted-by":"publisher","unstructured":"Rejeb A, Simske S, Rejeb K et al (2020) Internet of Things research in supply chain management and logistics: a bibliometric analysis. Internet Things (Netherlands) 12. https:\/\/doi.org\/10.1016\/j.iot.2020.100318","DOI":"10.1016\/j.iot.2020.100318"},{"key":"1239_CR25","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","volume":"11","author":"M Aria","year":"2017","unstructured":"Aria M, Cuccurullo C (2017) bibliometrix: an R-tool for comprehensive science mapping analysis. J Inf Secur 11:959\u2013975. https:\/\/doi.org\/10.1016\/j.joi.2017.08.007","journal-title":"J Inf Secur"},{"key":"1239_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"NJ van Eck","year":"2010","unstructured":"van Eck NJ, Waltman L (2010) Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84:523\u2013538. https:\/\/doi.org\/10.1007\/s11192-009-0146-3","journal-title":"Scientometrics"},{"key":"1239_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7324\/JAPS.2020.103002","volume":"10","author":"H Ram\u00edrez-Malule","year":"2020","unstructured":"Ram\u00edrez-Malule H, L\u00f3pez-Agudelo VA, G\u00f3mez-R\u00edos D (2020) Candida auris: a bibliometric analysis of the first ten years of research (2009-2018). J Appl Pharm Sci 10:12\u201321. https:\/\/doi.org\/10.7324\/JAPS.2020.103002","journal-title":"J Appl Pharm Sci"},{"key":"1239_CR28","doi-asserted-by":"publisher","unstructured":"Wang F, Liu J, Qiao X (2022) An empirical study on the relationship between scientific collaboration and knowledge production of the countries along the belt and road. Sustain 14. https:\/\/doi.org\/10.3390\/su142114489","DOI":"10.3390\/su142114489"},{"key":"1239_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0137856","volume":"10","author":"I Mayrose","year":"2015","unstructured":"Mayrose I, Freilich S (2015) The interplay between scientific overlap and cooperation and the resulting gain in co-authorship interactions. PLoS One 10:1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0137856","journal-title":"PLoS One"},{"key":"1239_CR30","doi-asserted-by":"publisher","unstructured":"Carolus H, Pierson S, Mu\u00f1oz JF et al (2021) Genome-wide analysis of experimentally evolved candida auris reveals multiple novel mechanisms of multidrug resistance. MBio 12. https:\/\/doi.org\/10.1128\/mBio.03333-20","DOI":"10.1128\/mBio.03333-20"},{"key":"1239_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1071\/ma22057","volume":"43","author":"L Irinyi","year":"2022","unstructured":"Irinyi L, Malik R, Meyer W (2022) Candida auris: the most talked about multidrug-resistant emerging fungal pathogen. Microbiol Aust 43:173\u2013176. https:\/\/doi.org\/10.1071\/ma22057","journal-title":"Microbiol Aust"},{"key":"1239_CR32","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/myc.13277","volume":"64","author":"S Aghaei Gharehbolagh","year":"2021","unstructured":"Aghaei Gharehbolagh S, Izadi A, Talebi M et al (2021) New weapons to fight a new enemy: a systematic review of drug combinations against the drug-resistant fungus Candida auris. Mycoses 64:1308\u20131316. https:\/\/doi.org\/10.1111\/myc.13277","journal-title":"Mycoses"},{"key":"1239_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1021\/acsami.9b20708.Inhibition","volume":"176","author":"D Reckziegel","year":"2019","unstructured":"Reckziegel D, Vachon-Presseau E, Petre B et al (2019) Inhibition of Candida auris biofilm formation on medical and environmental surfaces by silver nanoparticles. Physiol Behav 176:139\u2013148. https:\/\/doi.org\/10.1021\/acsami.9b20708.Inhibition","journal-title":"Physiol Behav"},{"key":"1239_CR34","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/21505594.2021.1908765","volume":"12","author":"A Hernando-Ortiz","year":"2021","unstructured":"Hernando-Ortiz A, Mateo E, Perez-Rodriguez A et al (2021) Virulence of Candida auris from different clinical origins in Caenorhabditis elegans and Galleria mellonella host models. Virulence 12:1063\u20131075. https:\/\/doi.org\/10.1080\/21505594.2021.1908765","journal-title":"Virulence"},{"key":"1239_CR35","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41591-021-01383-w","volume":"27","author":"DM Proctor","year":"2021","unstructured":"Proctor DM, Dangana T, Sexton DJ et al (2021) Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility. Nat Med 27:1401\u20131409. https:\/\/doi.org\/10.1038\/s41591-021-01383-w","journal-title":"Nat Med"},{"key":"1239_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9110778","volume":"9","author":"T Fasciana","year":"2020","unstructured":"Fasciana T, Cortegiani A, Ippolito M et al (2020) Candida auris: an overview of how to screen, detect, test and control this emerging pathogen. Antibiotics 9:1\u201314. https:\/\/doi.org\/10.3390\/antibiotics9110778","journal-title":"Antibiotics"},{"key":"1239_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3947\/IC.2022.0008","volume":"54","author":"A Sanyaolu","year":"2022","unstructured":"Sanyaolu A, Okorie C, Marinkovic A et al (2022) Candida auris: an overview of the emerging drug-resistant fungal infection. Infect Chemother 54:236\u2013246. https:\/\/doi.org\/10.3947\/IC.2022.0008","journal-title":"Infect Chemother"},{"key":"1239_CR38","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1128\/JCM.00319-11","volume":"49","author":"WG Lee","year":"2011","unstructured":"Lee WG, Shin JH, Uh Y et al (2011) First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol 49:3139\u20133142. https:\/\/doi.org\/10.1128\/JCM.00319-11","journal-title":"J Clin Microbiol"},{"key":"1239_CR39","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/myc.13250","volume":"64","author":"JV Mulet Bayona","year":"2021","unstructured":"Mulet Bayona JV, Salvador Garc\u00eda C, Tormo Palop N, Gimeno Cardona C (2021) Validation and implementation of a commercial real-time PCR assay for direct detection of Candida auris from surveillance samples. Mycoses 64:612\u2013615. https:\/\/doi.org\/10.1111\/myc.13250","journal-title":"Mycoses"},{"key":"1239_CR40","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/JCM.00367-15","volume":"53","author":"S Kathuria","year":"2015","unstructured":"Kathuria S, Singh PK, Sharma C et al (2015) Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by vitek 2, CL. J Clin Microbiol 53:1823\u20131830. https:\/\/doi.org\/10.1128\/JCM.00367-15","journal-title":"J Clin Microbiol"},{"key":"1239_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/mmy\/myaa049","volume":"59","author":"AM Borman","year":"2021","unstructured":"Borman AM, Fraser M, Johnson EM (2021) Chromagartmcandida plus: a novel chromogenic agar that permits the rapid identification of candida auris. Med Mycol 59:253\u2013258. https:\/\/doi.org\/10.1093\/mmy\/myaa049","journal-title":"Med Mycol"},{"key":"1239_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.mib.2019.05.008","volume":"52","author":"J Rhodes","year":"2019","unstructured":"Rhodes J, Fisher MC (2019) Global epidemiology of emerging Candida auris. Curr Opin Microbiol 52:84\u201389. https:\/\/doi.org\/10.1016\/j.mib.2019.05.008","journal-title":"Curr Opin Microbiol"},{"key":"1239_CR43","doi-asserted-by":"publisher","unstructured":"Suphavilai C, Ko KKK, Lim KM et al (2023) Discovery of the sixth Candida auris clade in Singapore Research in context Evidence before this study. medRxiv 2023.08.01.23293435. https:\/\/doi.org\/10.1101\/2023.08.01.23293435","DOI":"10.1101\/2023.08.01.23293435"},{"key":"1239_CR44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ijantimicag.2019.09.016","volume":"54","author":"YE Tan","year":"2019","unstructured":"Tan YE, Teo JQM, Rahman NBA et al (2019) Candida auris in Singapore: genomic epidemiology, antifungal drug resistance, and identification using the updated 8.01 VITEK\u24c72 system. Int J Antimicrob Agents 54:709\u2013715. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.09.016","journal-title":"Int J Antimicrob Agents"},{"key":"1239_CR45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1146\/annurev-micro-032521-015858","volume":"77","author":"A Chowdhary","year":"2023","unstructured":"Chowdhary A, Jain K, Chauhan N (2023) Candida auris genetics and emergence. Annu Rev Microbiol 77:583\u2013602. https:\/\/doi.org\/10.1146\/annurev-micro-032521-015858","journal-title":"Annu Rev Microbiol"},{"key":"1239_CR46","first-page":"1","volume":"19","author":"NA Chow","year":"2020","unstructured":"Chow NA, Mu\u00f1oz JF, Gade L et al (2020) Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. bioRxiv 19:1\u20133","journal-title":"bioRxiv"},{"key":"1239_CR47","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3201\/eid2509.190686","volume":"25","author":"NA Chow","year":"2019","unstructured":"Chow NA, De Groot T, Badali H et al (2019) Potential fifth clade of Candida auris, Iran, 2018. Emerg Infect Dis 25:1780\u20131781. https:\/\/doi.org\/10.3201\/eid2509.190686","journal-title":"Emerg Infect Dis"},{"key":"1239_CR48","doi-asserted-by":"publisher","unstructured":"Zhu YC, O\u2019Brien B, Leach L et al (2020) Laboratory analysis of an outbreak of Candida auris in New York from 2016 to 2018: Impact and lessons learned. J Clin Microbiol 58. https:\/\/doi.org\/10.1128\/JCM.01503-19","DOI":"10.1128\/JCM.01503-19"},{"key":"1239_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-015-1863-z","volume":"16","author":"S Chatterjee","year":"2015","unstructured":"Chatterjee S, Alampalli SV, Nageshan RK et al (2015) Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genom 16:1\u201316. https:\/\/doi.org\/10.1186\/s12864-015-1863-z","journal-title":"BMC Genom"},{"key":"1239_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1011190","volume":"19","author":"C Sharma","year":"2023","unstructured":"Sharma C, Kadosh D (2023) Perspective on the origin, resistance, and spread of the emerging human fungal pathogen Candida auris. PLoS Pathog 19:1\u201312. https:\/\/doi.org\/10.1371\/journal.ppat.1011190","journal-title":"PLoS Pathog"},{"key":"1239_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00517-21","volume":"65","author":"TG Maphanga","year":"2021","unstructured":"Maphanga TG, Naicker SD, Kwenda S et al (2021) In vitro antifungal resistance of candida auris isolates from bloodstream infections, South Africa. Antimicrob Agents Chemother 65:1\u201311. https:\/\/doi.org\/10.1128\/AAC.00517-21","journal-title":"Antimicrob Agents Chemother"},{"key":"1239_CR52","doi-asserted-by":"publisher","unstructured":"Jacobs SE, Jacobs JL, Dennis EK et al (2022) Candida auris pan-drug-resistant to four classes of antifungal agents. Antimicrob Agents Chemother 66. https:\/\/doi.org\/10.1128\/aac.00053-22","DOI":"10.1128\/aac.00053-22"},{"key":"1239_CR53","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","volume":"64","author":"SR Lockhart","year":"2017","unstructured":"Lockhart SR, Etienne KA, Vallabhaneni S et al (2017) Simultaneous emergence of multidrug-resistant candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64:134\u2013140. https:\/\/doi.org\/10.1093\/cid\/ciw691","journal-title":"Clin Infect Dis"},{"key":"1239_CR54","doi-asserted-by":"publisher","unstructured":"Healey KR, Kordalewska M, Ortigosa CJ et al (2018) Limited ERG11 mutations identified in isolates of candida auris directly contribute to reduced azole susceptibility. Antimicrob Agents Chemother 62. https:\/\/doi.org\/10.1128\/AAC.01427-18","DOI":"10.1128\/AAC.01427-18"},{"key":"1239_CR55","first-page":"23","volume":"23","author":"R Ben-Ami","year":"2018","unstructured":"Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S, Maor Y, Tarabia J, Schechner V, Amos Adler TF (2018) Multidrug-resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg Infect Dis 23:23","journal-title":"Emerg Infect Dis"},{"key":"1239_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00365-20","volume":"11","author":"JM Rybak","year":"2020","unstructured":"Rybak JM, Mu\u00f1oz JF, Barker KS et al (2020) Mutations in TAC1B: a novel genetic determinant of clinical fluconazole resistance in Candida auris. MBio 11:1\u201316. https:\/\/doi.org\/10.1128\/mBio.00365-20","journal-title":"MBio"},{"key":"1239_CR57","doi-asserted-by":"publisher","unstructured":"Rhodes J, Abdolrasouli A, Farrer RA et al (2018) Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris article. Emerg Microbes Infect 7. https:\/\/doi.org\/10.1038\/s41426-018-0045-x","DOI":"10.1038\/s41426-018-0045-x"},{"key":"1239_CR58","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmi.2021.11.024.In","volume":"28","author":"JM Rybak","year":"2023","unstructured":"Rybak JM, Barker KS, Mu\u00f1oz JF et al (2023) In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris. Clin Microbiol Infect 28:838\u2013843. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.024.In","journal-title":"Clin Microbiol Infect"},{"key":"1239_CR59","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1016\/S2666-5247(23)00114-3","volume":"4","author":"SK Mishra","year":"2023","unstructured":"Mishra SK, Yasir M, Willcox M (2023) Candida auris: an emerging antimicrobial-resistant organism with the highest level of concern. The Lancet Microbe 4:e482\u2013e483. https:\/\/doi.org\/10.1016\/S2666-5247(23)00114-3","journal-title":"The Lancet Microbe"},{"key":"1239_CR60","doi-asserted-by":"publisher","first-page":"323","DOI":"10.53854\/liim-3103-6","volume":"31","author":"F Pallotta","year":"2023","unstructured":"Pallotta F, Viale P, Barchiesi F (2023) Candida auris: the new fungal threat. Infez Med 31:323\u2013328. https:\/\/doi.org\/10.53854\/liim-3103-6","journal-title":"Infez Med"},{"key":"1239_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9090539","volume":"9","author":"M Ghannoum","year":"2020","unstructured":"Ghannoum M, Arendrup MC, Chaturvedi VP et al (2020) Ibrexafungerp: a novel oral triterpenoid antifungal in development for the treatment of candida auris infections. Antibiotics 9:1\u201313. https:\/\/doi.org\/10.3390\/antibiotics9090539","journal-title":"Antibiotics"},{"key":"1239_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.01735-19","volume":"64","author":"S Alkhazraji","year":"2020","unstructured":"Alkhazraji S, Gebremariam T, Alqarihi A et al (2020) Fosmanogepix (APX001) is effective in the treatment of immunocompromised mice infected with invasive pulmonary scedosporiosis or disseminated fusariosis. Antimicrob Agents Chemother 64:1\u201312. https:\/\/doi.org\/10.1128\/AAC.01735-19","journal-title":"Antimicrob Agents Chemother"},{"key":"1239_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof6040239","volume":"6","author":"KJ Shaw","year":"2020","unstructured":"Shaw KJ, Ibrahim AS (2020) Fosmanogepix: a review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections. J Fungi 6:1\u201321. https:\/\/doi.org\/10.3390\/jof6040239","journal-title":"J Fungi"},{"key":"1239_CR64","doi-asserted-by":"publisher","unstructured":"Maphanga TG, Mpembe RS, Naicker SD, Govender NP (2022) In vitro antifungal activity of manogepix and other antifungal agents against South African Candida auris isolates from bloodstream infections. Microbiol Spectr 10. https:\/\/doi.org\/10.1128\/spectrum.01717-21","DOI":"10.1128\/spectrum.01717-21"},{"key":"1239_CR65","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2147\/IDR.S375625","volume":"16","author":"F Lamoth","year":"2023","unstructured":"Lamoth F (2023) Novel therapeutic approaches to invasive Candidiasis: considerations for the clinician. Infect Drug Resist 16:1087\u20131097. https:\/\/doi.org\/10.2147\/IDR.S375625","journal-title":"Infect Drug Resist"},{"key":"1239_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.01975-18","volume":"63","author":"G Tetz","year":"2019","unstructured":"Tetz G, Collins M, Vikina D, Tetz V (2019) In vitro activity of a novel antifungal compound , MYC-053 , against clinically significant antifungal-resistant strains of. Antimicrob Agents Chemother 63:1\u20138. https:\/\/doi.org\/10.1128\/AAC.01975-18 Copyright","journal-title":"Antimicrob Agents Chemother"},{"key":"1239_CR67","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1016\/j.apsb.2022.08.001","volume":"12","author":"J Tu","year":"2022","unstructured":"Tu J, Liu N, Huang Y et al (2022) Small molecules for combating multidrug-resistant superbug Candida auris infections. Acta Pharm Sin B 12:4056\u20134074. https:\/\/doi.org\/10.1016\/j.apsb.2022.08.001","journal-title":"Acta Pharm Sin B"},{"key":"1239_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02233-18","volume":"63","author":"NP Wiederhold","year":"2019","unstructured":"Wiederhold NP, Lockhart SR, Najvar LK et al (2019) The fungal Cyp51-specific inhibitor VT-1598 demonstrates in vitro and in vivo activity against Candida auris. Antimicrob Agents Chemother 63:1\u20139. https:\/\/doi.org\/10.1128\/AAC.02233-18","journal-title":"Antimicrob Agents Chemother"},{"key":"1239_CR69","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1093\/jac\/dkz280","volume":"74","author":"SM Rudramurthy","year":"2019","unstructured":"Rudramurthy SM, Colley T, Abdolrasouli A et al (2019) In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris. J Antimicrob Chemother 74:2943\u20132949. https:\/\/doi.org\/10.1093\/jac\/dkz280","journal-title":"J Antimicrob Chemother"},{"key":"1239_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02233-18","volume":"65","author":"D Candida","year":"2021","unstructured":"Candida D, Chu S, Long L et al (2021) A second-generation Fungerp Analog, SCY-247, shows potent in vitro activity against Candida auris and other clinically relevant fungal isolates. Antimicrob Agents Chemother 65:1\u20136. https:\/\/doi.org\/10.1128\/AAC.02233-18","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-01239-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-023-01239-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-01239-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T06:18:24Z","timestamp":1709878704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-023-01239-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["1239"],"URL":"https:\/\/doi.org\/10.1007\/s42770-023-01239-0","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"assertion":[{"value":"29 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with humans or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}